Literature DB >> 25447971

Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours.

Carla Cappelli1, Ugo Boggi, Salvatore Mazzeo, Rosa Cervelli, Daniela Campani, Niccola Funel, Benedetta Pontillo Contillo, Carlo Bartolozzi.   

Abstract

OBJECTIVES: Preoperative suspicion of malignancy in pancreatic neuroendocrine tumours (pNETs) is mostly based on tumour size. We retrospectively reviewed the contrast enhancement pattern (CEP) of a series of pNETs on multiphasic multidetector computed tomography (MDCT), to identify further imaging features predictive of lesion aggressiveness.
METHODS: Sixty pNETs, diagnosed in 52 patients, were classified based on CEP as: type A showing early contrast enhancement and rapid wash-out; type B presenting even (B1) or only (B2) late enhancement. All tumours were resected allowing pathologic correlations.
RESULTS: Nineteen pNETs showed type A CEP (5-20 mm), 29 type B1 CEP (5-80 mm) and 12 type B2 (15-100 mm). All tumours were classified as well differentiated tumours, 19 were benign (WDt-b), 15 with uncertain behaviour (WDt-u) and 26 carcinomas (WDC). None of A lesions were malignant (12 WDt-b; 7 WDt-u), all B2 lesions were WDC, 7 B1 lesions were WDt-b, 8 WDt-u and 14 WDC; 4/34 (12 %) lesions ≤2cm were WDC. CEP showed correlation with all histological prognostic indicators.
CONCLUSIONS: Correlating with the lesion grading and other histological prognostic predictors, CEP may preoperatively suggest the behaviour of pNETs, assisting decisions about treatment. Moreover CEP allows recognition of malignant small tumours, incorrectly classified on the basis of their dimension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25447971     DOI: 10.1007/s00330-014-3485-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection.

Authors:  T Ichikawa; M S Peterson; M P Federle; R L Baron; H Haradome; Y Kawamori; S Nawano; T Araki
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

Review 2.  Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel
Journal:  Endocr Relat Cancer       Date:  2011-10-17       Impact factor: 5.678

3.  Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors.

Authors:  Yu Takahashi; Yuri Akishima-Fukasawa; Noritoshi Kobayashi; Tsuyoshi Sano; Tomoo Kosuge; Yuji Nimura; Yae Kanai; Nobuyoshi Hiraoka
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

Review 4.  Neuroendocrine neoplasms of the gut and pancreas: new insights.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2011-08-02       Impact factor: 43.330

Review 5.  Multi-detector row CT of pancreatic islet cell tumors.

Authors:  Karen M Horton; Ralph H Hruban; Charles Yeo; Elliot K Fishman
Journal:  Radiographics       Date:  2006 Mar-Apr       Impact factor: 5.333

Review 6.  Pancreatic endocrine tumors.

Authors:  Niraj Jani; A James Moser; Asif Khalid
Journal:  Gastroenterol Clin North Am       Date:  2007-06       Impact factor: 3.806

Review 7.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

8.  Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.

Authors:  L Fischer; J Kleeff; I Esposito; U Hinz; A Zimmermann; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2008-05       Impact factor: 6.939

9.  Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.

Authors:  Stefano La Rosa; Catherine Klersy; Silvia Uccella; Linda Dainese; Luca Albarello; Angelica Sonzogni; Claudio Doglioni; Carlo Capella; Enrico Solcia
Journal:  Hum Pathol       Date:  2008-08-20       Impact factor: 3.466

10.  The ENETS guidelines: the new TNM classification system.

Authors:  Guido Rindi
Journal:  Tumori       Date:  2010 Sep-Oct
View more
  16 in total

1.  Deep learning for World Health Organization grades of pancreatic neuroendocrine tumors on contrast-enhanced magnetic resonance images: a preliminary study.

Authors:  Xuan Gao; Xiaolin Wang
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-09-26       Impact factor: 2.924

2.  Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.

Authors:  E Belousova; G Karmazanovsky; A Kriger; D Kalinin; L Mannelli; A Glotov; N Karelskaya; O Paklina; A Kaldarov
Journal:  Clin Radiol       Date:  2016-11-24       Impact factor: 2.350

3.  Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.

Authors:  Yun Bian; Zengrui Zhao; Hui Jiang; Xu Fang; Jing Li; Kai Cao; Chao Ma; Shiwei Guo; Li Wang; Gang Jin; Jianping Lu; Jun Xu
Journal:  J Magn Reson Imaging       Date:  2020-04-28       Impact factor: 4.813

Review 4.  State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors.

Authors:  Eric P Tamm; Priya Bhosale; Jeffrey H Lee; Eric M Rohren
Journal:  Surg Oncol Clin N Am       Date:  2016-04       Impact factor: 3.495

5.  Sporadic insulinomas on volume perfusion CT: dynamic enhancement patterns and timing of optimal tumour-parenchyma contrast.

Authors:  Liang Zhu; Wen-Ming Wu; Hua-Dan Xue; Wei Liu; Xuan Wang; Hao Sun; Ping Li; Yu-Pei Zhao; Zheng-Yu Jin
Journal:  Eur Radiol       Date:  2017-01-20       Impact factor: 5.315

Review 6.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

Review 7.  Texture Analysis: An Emerging Clinical Tool for Pancreatic Lesions.

Authors:  Adam M Awe; Victoria R Rendell; Meghan G Lubner; Emily R Winslow
Journal:  Pancreas       Date:  2020-03       Impact factor: 3.243

8.  Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.

Authors:  Chuangen Guo; Xiao Chen; Zhongqiu Wang; Wenbo Xiao; Qidong Wang; Ke Sun; Xiaoling Zhuge
Journal:  Oncotarget       Date:  2017-06-27

9.  Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.

Authors:  Chuangen Guo; Xiaoling Zhuge; Xiao Chen; Zhongqiu Wang; Wenbo Xiao; Qidong Wang
Journal:  Oncol Lett       Date:  2017-04-11       Impact factor: 2.967

10.  Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.

Authors:  Chuangen Guo; Xiao Chen; Wenbo Xiao; Qidong Wang; Ke Sun; Zhongqiu Wang
Journal:  Onco Targets Ther       Date:  2017-03-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.